SARS-CoV-2エンベロープタンパク質のオリゴメリック状態と薬物結合は,エクトドメインに敏感である

Noah H Somberg¹, Iva Sučec¹, João Medeiros-Silva¹

¹Department of Chemistry, Massachusetts Institute of Technology, 170 Albany Street, Cambridge, Massachusetts 02139, United States.

Journal of the American Chemical Society

|August 21, 2024

まとめ

SARS-CoV-2エンベロープ (E) タンパク質は,ペンタマーだけでなく,複数の形態で存在します. 新しい阻害剤AV-352はEタンパク質ジマーを標的にし,新たな抗ウイルス戦略を提供している.

科学分野:

ウイルス学
構造生物学
生物化学

背景:

SARS-CoV-2エンベロープ (E) タンパク質は,ウイルスの芽生えとイオンチャネル活動に不可欠であり,病原性に貢献します.
以前の研究では,Eタンパク質のトランスメブラン領域 (ETM) が脂質二層にペンタマーを形成することを示唆していた.
Eタンパク質の機能と薬物相互作用の構造的根拠は不明である.

研究の目的:

エクトドメインを含むEタンパク質構造体 (ENTM) の小分子構造を調査する.
新しい阻害剤であるAV-352とEタンパク質の相互作用を研究する.
Eタンパク質の多様な機能と潜在的薬物標的の構造的基礎を理解する.

主な方法:

脂質二層におけるENTMオリゴメア状態を決定するために19Fスピン拡散NMRを使用した.
阻害剤の活性 (AV-352 vs. HMA) を評価するために,ウイルスのような粒子の測定法を使用した.
タンパク質と薬物の相互作用をマッピングするために 13C-19F 距離 NMR 技術を適用しました.

主要な成果:

ENTMは,以前に報告されたペンタメリックETMとは対照的に,脂質二重層の平均二次状態を採用しています.
新しい阻害剤AV-352は,HMAと比較してEタンパク質に対する活性が強くなっています.
AV-352は,Eタンパク質のトランスメブラン領域のC端部と結合する.

結論:

SARS-CoV-2 Eタンパク質は,脂質二重層に複数のオリゴメール状態 (例えば,ジマーおよびペンタマー) で存在することがあります.
これらの異なるオリゴメリック形態は,異なる機能を持つ可能性があります.
AV-352が二重形に特異的に結合することは,標的型抗ウイルス療法の可能性を示唆する.

さらに関連する動画

08:07

Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques

Published on: January 12, 2024

690

12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

1.6K

関連する概念動画

01:29

The Two-State Receptor Model

1.9K

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...

1.9K

02:50

Conjugated Proteins

18.2K

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...

18.2K

02:40

Ligand Binding Sites

12.8K

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

12.8K

01:58

Cooperative Allosteric Transitions

7.9K

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...

7.9K

01:29

Drug-Receptor Interactions

5.1K

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....